ArticleJournal of personalized medicine2024

Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients.

Ziv Savin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.